OBJECTIVE: Aim of this study was the assessment of the prevalence of eating disorders, and of eating disorder symptoms, in obese patients with type 2 diabetes, compared to non-diabetic subjects. DESIGN: Three samples of individuals were studied: a series of 156 (76 male, 80 female) overweight and obese type 2 diabetic patients, aged 30 -65 y, with a body mass index (BMI) > 28 kg=m 2 (DM); a series of 192 (20 male, 172 female) obese (BMI > 30 kg=m 2 ) non-diabetic patients aged 30 -65 y seeking treatment for weight loss (OC); and a non-clinical sample of 48 (22 male, 26 female) obese (BMI > 30 kg=m 2 ) subjects aged 30 -65 y selected from the lists of two general practices (OP). Eating behavior was assessed using the Eating Disorder Examination (EDE 12.0D). RESULTS: The prevalence of Binge Eating Disorder was lower than 5% in all the three samples. Median EDE scores in females were significantly higher in OC (3.0) and OP (3.4) than in DM (1.7), while diabetic patients showed higher scores on Restraint than both non-diabetic samples. Among diabetic patients, a significant correlation of EDE scores with HbA 1 c was observed. CONCLUSIONS: Type 2 diabetes is unlikely to induce relevant eating disturbances in obese patients, apart from an increase in restraint. Abnormalities of eating attitudes and behavior are associated with an impairment of metabolic control.
Introduction
Several studies have been performed in order to evaluate the possible role of diabetes mellitus as a risk factor for eating disorders. Although some earlier studies performed with selfreported questionnaires reported a high prevalence of anorexia nervosa and bulimia nervosa in young diabetic females, 1 controlled surveys with interview-based diagnoses always failed to detect any significant difference in the prevalence of eating disorders between type 1 diabetic individuals and control subjects. 2 -7 However, different studies have shown that minor eating disturbances in type 1 diabetes are frequent, and they are associated to remarkable impairment of metabolic control. 2,7 -11 Few studies have been addressed to the assessment of eating attitudes and behaviors in patients with type 2 diabetes. 12 -14 The typical age of onset of type 2 diabetes is much higher than that of eating disorders; for this reason, this disease is unlikely to represent a risk factor for the development of eating disorders. It should also be considered, however, that most type 2 diabetic patients are obese, and that obesity is often associated with minor eating disturbances; in fact, binge eating has been reported to be frequent among type 2 diabetic patients. 12 -14 Dietary restraint could facilitate the onset of minor eating disturbances, as proposed for type 1 diabetic patients. 15 Furthermore, eating disorders could facilitate, at least theoretically, the onset of type 2 diabetes; in fact, disturbances of eating behavior could promote weight gain, and excess weight is a well-known risk factor for the development of type 2 diabetes. In the only controlled study published to date, newly diagnosed type 2 diabetic patients did not show any significant difference in eating behavior when compared to matched controls, 13 but the sample could have been too small to detect minor differences. It should also be considered that abnormalities of eating behavior can affect considerably body weight and metabolic control in type 2 diabetes. 14 The aim of this study was the assessment of the prevalence of eating disorders, and of eating disorder symptoms, in overweight and obese patients with type 2 diabetes, compared to non-diabetic obese subjects.
Methods
The study was designed as a cross-sectional, controlled survey. Three samples of subjects were studied. The first sample was overweight and obese patients with type 2 diabetes (DM): all patients with known type 2 diabetes, aged 30 -65 y, with a duration of diabetes of at least 1 y and with body mass index (BMI) > 28 kg=m 2 attending the Outpatient Clinic of Metabolic Diseases and Diabetology of the University of Florence for the treatment of diabetes between 1 January 1998 and 31 August 1999, were asked to participate to the study, unless they met one of the following exclusion criteria:
physical illnesses known to interfere considerably with eating behavior, such as untreated thyroid disorders and gastrointestinal diseases; known mental disorders, such as schizophrenia, substance or alcohol dependence, or mental retardation, which could affect the ability to answer the interviewer's questions; current medication with psychotropic drugs known to interfere with eating behavior, such as anti-epileptics, anti-depressants and anti-psychotics; pregnancy or lactation. Of the 161 patients invited, five refused to participate, with a response rate of 96.9%. Non-participants did not differ significantly from participants for any of the characteristics studied (data available upon request). The final sample was therefore composed of 156 patients who provided their written informed consent, and whose characteristics are summarized in Table 1 . Among the patients studied, 26 were treated with diet only, 83 with oral hypoglycemic agents (21 with metformin, 15 with sulphonylureas, 11 with acarbose and 36 with combinations of different drugs), 21 with combinations of insulin and hypoglycemic agents, and 26 with insulin only. Of the patients studied, 32 were affected by diabetic retinopathy, 31 by diabetic neuropathy, 18 by coronary artery disease, 15 by nephropathy and 11 by obstructive arteriopathy of the lower limbs; 80 patients were not affected by any complication, 51 showed one complication, 20 were affected by two complications, and five by three or more complications.
The second sample was obese non-diabetic subjects, clinical sample (OC): all non-diabetic patients aged 30 -65 y, with a BMI > 30 kg=m 2 attending for the first time the Outpatient Clinic for the treatment of obesity between 1 January 1998 and 31 August 1999 were invited to participate in the study, unless they met one of the exclusion criteria described above. The presence of diabetes was excluded through the determination of fasting blood glucose ( < 126 mg=dl), and the measurement of glycemia 2 h after an oral glucose load of 75 g ( < 200 mg=dl). Of the 195 invited patients, three refused to participate, while 192 were enrolled in the study, after having provided their written informed consent. The response rate was therefore 98.5%. The age of patients in the OC group was significantly lower when compared to DM, in both sexes (P < 0.05 at Student's unpaired t-test), while differences in BMI were not statistically significant. Most of the patients reported to have already tried to lose weight previously, but none of them was currently attending any weight loss program at the time of the assessment.
A third, non-diabetic sample of obese subjects (OP) selected from the general population was studied, for the comparison with diabetic individuals not seeking weight loss. The clinical sample of obese non-diabetic patients was composed of individuals who were actively seeking weight loss; on the other hand, diabetic patients were attending the Outpatient Clinic for the treatment of diabetes, and not specifically for weight loss. This difference in motivation could account for differences in eating behavior.
14 All subjects regularly living in Italy receive free general practice care provided by the National Health Service and are therefore listed in the files of one of the registered general practitioners. Two general practitioners with their practices in a suburban area of Florence, who kept regular clinical records of all their enlisted patients, were asked to identify, among Eating behavior in obese type 2 diabetes E Mannucci et al their patients, those obese non-diabetic subjects meeting the inclusion criteria described above for the clinical sample. The patients selected received a letter signed by the general practitioner and the investigator, inviting them to participate in the study, and then were contacted by the investigator by telephone. Those who agreed to participate were invited into the general practitioner's office, where they underwent the assessment of eating attitudes and behavior, as described below. Subjects in this sample were not seeking medical advice or care, and they can therefore be considered a non-clinical sample. Of the 59 patients invited, eight refused to participate, with a response rate of 86.4%; the demographic characteristics of non-participants were not significantly different from those of participants (data available upon request). Of the 51 enrolled, three were subsequently excluded for violation of the inclusion criteria (two were taking anti-depressant medication, and one was a pregnant woman), so that the final sample was composed of 48 subjects. The characteristics of the OP group were not significantly different from those of the OC group, as summarized in Table 1 . All subjects enrolled were interviewed by a trained investigator (MDB), using the Eating Disorder Examination (EDE 12.0D; 16). The EDE is a semistructured interview designed for the assessment of the specific psychopathology of eating disorders, which provides operational diagnoses according to the criteria of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV 17 ) , showing high concordance rates with other validated diagnostic instruments.
18 EDE 12.0D consists of four subscales: Restraint (EDE-R), Eating Concern (EDE-E), Weight Concern (EDE-W) and Shape Concern (EDE-S), plus several items that assess the frequency of binge eating and compensatory behaviors. The global score provides a measure of the severity of the eating disorder, while the subscale scores define the psychopathological profile of individual patients. 16 Although specifically designed for the study of patients with bulimia nervosa, anorexia nervosa and Binge Eating Disorder (BED), the EDE has also been used in obese patients, 19 as well as in subjects with type 2 diabetes. 13 In the present study, the interview was performed in its validated Italian translation. 20 The present study is an exploratory survey, and the size of the samples is not based on power calculations. In fact, in the hypothesis of a prevalence of BED of 4%, a sample of over 2000 patients for each group would be required in order to have a 90% chance of detecting as statistically significant (P < 0.05) a 50% difference in prevalence between groups. 21 Comparisons between psychometric scores was included, as this could enhance the power to detect differences between groups.
Haemoglobin A 1 c was measured by HPLC (instrument HA 8121, Menarini Diagnostics). The reference range for non diabetic patients was 3.81 -5.51%.
Prevalence data in different samples were compared using the chi-square test. Numerical scores of EDE, which have a non-normal distribution, were expressed as median (25th -75th percentile), and compared in different groups using the Mann -Whitney U-test, with a significance threshold of P < 0.05. Other variables with normal distribution, such as BMI, age and HbA 1 c, were expressed as mean AE standard deviation and compared with unpaired Student's t-test. Multivariate analysis of determinants of
Results
The diagnosis of BED was made in two female diabetic patients, eight (seven female, one male) non-diabetic obese patients from the clinical sample (OC), and one female obese non-diabetic subject from the non-clinical sample (OP). The observed prevalence of BED in females was therefore 2.5, 4.1 and 3.6% in DM, OC, and OP, respectively; in males, the prevalence was 0.5 and 0%, respectively. The difference of prevalence in females between the DM group and the two combined samples of non-diabetic subjects was not statistically significant.
None of the subjects studied were found to be affected by bulimia nervosa. Total EDE 12.0D scores in the three samples studied are summarized in Figure 1 . EDE sub-scale scores are reported in Table 2 .
Binge eating episodes (ie 'objective bulimic' episodes in the definition provided by the EDE 12.0D) during the last month, were reported by eight (six female, two male) patients with diabetes, 24 (22 female, two male) obese subjects from the clinical sample, and four (three female, one male) obese individuals from the population sample. In Figure 1 Total EDE scores in obese patients with type 2 diabetes (DM), and non-diabetic obese individuals from clinical (OC) and non-clinical (OP) samples.
Eating behavior in obese type 2 diabetes E Mannucci et al females, binge eating was therefore present in 7.5% of diabetic patients, 12.8% of obese patients from the clinical sample, and 3.8% of obese patients from the population sample. Among males, the prevalence of binge eating was 2.6, 10 and 4.5%, respectively. Differences among groups were not statistically significant. Among those who reported binge eating, the number of episodes during the last month was four 2 -7 in diabetic females, and three 2 -8 in obese females from the clinical sample.
Spearman's correlation coefficients (r) of EDE total and subscale scores with demographic and clinical variables in diabetic patients are reported in Table 3 . Age showed an inverse correlation with EDE-S, while duration of diabetes was inversely correlated to EDE-E. No significant correlation was observed between BMI and EDE scores, while HbA 1 c was significantly correlated to EDE-T, EDE-E, EDE-S and EDE-W, but not EDE-R scores. No significant difference in EDE total and sub-scale scores was observed among patients with different hypoglycemic treatment. In the clinical sample of obese non-diabetic patients, a significantly inverse correlation of age was observed with EDE-S (r ¼ 7 0.30, P < 0.01), EDE-W (r ¼ 7 0.20, P < 0.05), and EDE-E (r ¼ 7 0.23, P < 0.05), but not with EDE-R and EDE-T; BMI values did not show any significant correlation with EDE scores. In the non-clinical sample of obese subjects, there was a significant correlation between EDE-S and age (r ¼ 7 0.35, P < 0.05).
Considering that the samples of diabetic and non-diabetic individuals differed for age, multivariate analysis was performed, in order to assess the specific effect of diabetes on EDE scores, after adjusting for age. Combining the three samples together, and using a multiple linear regression model including age, BMI and diagnosis of diabetes (dummy variable), in females, EDE total scores were inversely correlated to age (adjusted r ¼ 7 0.18, P < 0.05), but not to BMI or diabetes; in males, no significant correlation was found. Among EDE sub-scales, EDE-R (Restraint) showed an inverse correlation with BMI in females (adjusted r ¼ 7 0.25, P < 0.01), but not in males; EDE-E (Eating Concern) was directly correlated with BMI in males (adjusted r ¼ 0.32, P < 0.01); EDE-S (Shape Concern) was inversely correlated with age in females (adjusted r ¼ 0.39, P < 0.01); EDE-W (Weight Concern) showed a negative correlation with age in females (adjusted r ¼ 7 0.32, P < 0.01) and correlated with BMI in males (adjusted r ¼ 0.22, P < 0.05). The diagnosis of diabetes was associated with significantly higher scores (P < 0.01) of EDE-R, but not of other EDE subscales, in both sexes.
No significant difference in EDE total and subscale score was observed between insulin-treated and non-insulin treated diabetic patients, in both sexes; among those who were not treated with insulin, patients on hypoglycemic agents did not show any difference in EDE scores when compared to those who were not receiving any pharmacological treatment for diabetes. Among those treated with oral hypoglycemic agents, no significant difference in EDE scores was observed between patients treated with different drugs (data not shown).
Discussion
The prevalence of eating disorders in overweight and obese patients with type 2 diabetes was not significantly different from that of non-diabetic obese individuals. No cases of bulimia nervosa were observed; this finding was expected, considering the mean age of the sample studied. 22 The prevalence of BED in obese non-diabetic subjects was lower than that reported in previous surveys; 23 -25 this difference could be due to diversities in assessment methods or to differences in the prevalence of BED in different countries. 26 No difference in the prevalence of BED was observed between diabetic and non diabetic subjects, confirming the result of a previous study; 13 however, the small size of the sample could have prevented the observation of minor differences. Diabetic females showed lower total EDE scores than obese non diabetic subjects; this could be due to the { DM ¼ type 2 diabetic obese patients; OC ¼ obese non-diabetic patients, clinical sample; OP ¼ obese non-diabetic subjects, non-clinical sample. EDE-R ¼ restraint; EDE-E ¼ eating concern; EDE-W ¼ weight concern; EDE-S ¼ shape concern. Data are expressed as median (25th -75th percentile). *P < 0.05 vs OC and vs OP; { P < 0.05 vs males; { P < 0.05 vs DM. Eating behavior in obese type 2 diabetes E Mannucci et al higher age of diabetic patients. Similar results were observed with the Shape Concern score, which is also inversely correlated with age. A lower BMI in diabetic patients could also have contributed to differences in EDE total and subscale scores between diabetic and non diabetic individuals. In fact, differences in EDE total and Shape Concern scores disappeared at multivariate analysis after adjustment for age and BMI. In both sexes, diabetic patients showed higher scores on the Restraint sub-scale than obese non-diabetic controls, both from the clinical and non-clinical sample; the difference was confirmed at multivariate analysis, after adjusting for age and BMI. This difference could be due to the dietary prescriptions and to the increase of the awareness of weight which follows the diagnosis of DM. 13 It is noteworthy that the overweight and obese patients with type 2 diabetes show higher restraint levels when compared to obese non-diabetic patients who are actively seeking weight loss. This suggests that the diagnosis of a disease such as diabetes could improve the patient's motivation for weight loss, and therefore be more effective in enhancing restriction. Some drugs used in the treatment of diabetes, such as acarbose and metformin, could have contributed to differences in eating attitudes and behavior between diabetic and non diabetic subjects. In the present sample, no difference in EDE restraint scores was observed between groups of patients receiving different hypoglycemic treatment, but the size of the sample was inadequate for such a comparison. Binge eating episodes were reported by a relevant minority of the subjects studied, in all the three samples. This confirms previous reports on the frequency of loss of control over eating in obese diabetic and non-diabetic individuals. 12 -14 No difference was observed in the prevalence of binge eating behavior between diabetic and non-diabetic subjects, suggesting that type 2 diabetes is not a risk factor for eating binges. On the other hand, eating attitudes and behaviors appear to affect in a relevant manner metabolic control in patients with type 2 diabetes. In fact, HbA 1 c is significantly correlated to EDE total scores, and to Shape Concern, Eating Concern and Weight Concern scores.
In obese non-diabetic patients, EDE scores were correlated to age, but not to BMI, confirming previous reports. 18 In the non-clinical sample, only Shape Concern scores showed a significant inverse correlation with age; however, the small size of the sample could have prevented the detection of other correlations. A similar inverse correlation between Shape Concern and age was observed in diabetic patients, confirming that preoccupation with body image tends to decrease with advancing age. Interestingly, Eating Concern was inversely correlated with duration of diabetes. It can be speculated that newly diagnosed patients, who receive a large amount of information about the relevance of dietary habits for metabolic control, become more aware of the importance of eating habits, and are therefore more concerned about their ability to control food intake; on the other hand, those with a longer duration of diabetes could become more accustomed to dietary prescription, and be less concerned with loss of control over eating. The sample of diabetic patients studied was a consecutive series of subjects with type 2 diabetes attending a hospital-based outpatient clinic. This sample cannot be considered representative of all subjects with type 2 diabetes in the general population, as patients not attending specialized clinics could have different characteristics. However, it should be considered that over two-thirds of patients with known type 2 diabetes in Italy routinely attend hospital-based clinics such as the one in which the study was performed.
The diabetic subjects were compared with non-diabetic obese individuals, using both clinic-based and populationbased control samples. In fact, clinical samples of obese nondiabetic patients seeking treatment for weight loss have a different motivation when compared to clinical samples of type 2 diabetic patients seeking diabetes treatment, and this could be associated with diversities in eating attitudes and behavior. The sample of obese patients not seeking weight loss, although small, provides additional information about the differences in eating behavior associated with type 2 diabetes. The control sample of obese non-diabetic patients was not age and BMI matched with the diabetic sample; however, the interference of differences of age and BMI was explored with multivariate analysis.
In conclusion, the prevalence of BED in the present sample patients with type 2 diabetes was not higher than in obese non-diabetic subjects. The diagnosis of type 2 diabetes was associated with an increase in restraint, but no other relevant modification in eating attitudes. However, since even minor eating disturbances can remarkably affect metabolic control, the assessment of eating attitudes and behavior in patients with type 2 diabetes is clinically relevant, particularly in those with unsatisfactory blood glucose levels.
